McDermott Michael 4
4 · PFIZER INC · Filed Feb 25, 2025
Insider Transaction Report
Form 4
PFIZER INCPFE
McDermott Michael
Executive Vice President
Transactions
- Tax Payment
Common Stock
2025-02-22$26.08/sh−9,925$258,844→ 77,214 total - Exercise/Conversion
Common Stock
2025-02-22$30.17/sh+11,125$335,641→ 87,636 total - Exercise/Conversion
Stock Appreciation Rights
2025-02-22−11,125→ 0 totalExercise: $30.17From: 2025-02-22Exp: 2025-02-22→ Common Stock (11,125 underlying) - Tax Payment
Common Stock
2025-02-22$26.30/sh−497$13,071→ 87,139 total
Footnotes (5)
- [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
- [F3]Price is the closing price of Pfizer common stock on February 21, 2025.
- [F4]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F5]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.